These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2192 related articles for article (PubMed ID: 34225483)

  • 21. Triclosan targeting of gut microbiome ameliorates hepatic steatosis in high fat diet-fed mice.
    Sun D; Zuo C; Huang W; Wang J; Zhang Z
    J Antibiot (Tokyo); 2022 Jun; 75(6):341-353. PubMed ID: 35440769
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Perilla Oil Has Similar Protective Effects of Fish Oil on High-Fat Diet-Induced Nonalcoholic Fatty Liver Disease and Gut Dysbiosis.
    Tian Y; Wang H; Yuan F; Li N; Huang Q; He L; Wang L; Liu Z
    Biomed Res Int; 2016; 2016():9462571. PubMed ID: 27051672
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Folic acid attenuates high-fat diet-induced steatohepatitis
    Xin FZ; Zhao ZH; Zhang RN; Pan Q; Gong ZZ; Sun C; Fan JG
    World J Gastroenterol; 2020 May; 26(18):2203-2220. PubMed ID: 32476787
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bisphenol A induced hepatic steatosis by disturbing bile acid metabolism and FXR/TGR5 signaling pathways via remodeling the gut microbiota in CD-1 mice.
    Hong T; Zou J; He Y; Zhang H; Liu H; Mai H; Yang J; Cao Z; Chen X; Yao J; Feng D
    Sci Total Environ; 2023 Sep; 889():164307. PubMed ID: 37211107
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pathogenic effects of Desulfovibrio in the gut on fatty liver in diet-induced obese mice and children with obesity.
    Lin YC; Lin HF; Wu CC; Chen CL; Ni YH
    J Gastroenterol; 2022 Nov; 57(11):913-925. PubMed ID: 35976494
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Targeting the gut microbiota with resveratrol: a demonstration of novel evidence for the management of hepatic steatosis.
    Wang P; Wang J; Li D; Ke W; Chen F; Hu X
    J Nutr Biochem; 2020 Jul; 81():108363. PubMed ID: 32388250
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of Ilex hainanensis Merr. On HFD-induced nonalcoholic fatty liver disease and rebalance of gut microbiota and bile acids metabolism in mice.
    Tian JY; Xiao M; Zhao WW; Wu X; Yang J; Chen XQ
    Fitoterapia; 2024 Oct; 178():106186. PubMed ID: 39142527
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dynamic alterations in the gut microbiota and metabolome during the development of methionine-choline-deficient diet-induced nonalcoholic steatohepatitis.
    Ye JZ; Li YT; Wu WR; Shi D; Fang DQ; Yang LY; Bian XY; Wu JJ; Wang Q; Jiang XW; Peng CG; Ye WC; Xia PC; Li LJ
    World J Gastroenterol; 2018 Jun; 24(23):2468-2481. PubMed ID: 29930468
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mitigation of high-fat diet-induced hepatic steatosis by thyme (
    Sheng X; Zhan P; Wang P; He W; Tian H
    Food Funct; 2024 Jul; 15(14):7333-7347. PubMed ID: 38305590
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dietary cholesterol drives fatty liver-associated liver cancer by modulating gut microbiota and metabolites.
    Zhang X; Coker OO; Chu ES; Fu K; Lau HCH; Wang YX; Chan AWH; Wei H; Yang X; Sung JJY; Yu J
    Gut; 2021 Apr; 70(4):761-774. PubMed ID: 32694178
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Advanced liver steatosis accompanies an increase in hepatic inflammation, colonic, secondary bile acids and Lactobacillaceae/Lachnospiraceae bacteria in C57BL/6 mice fed a high-fat diet.
    Zeng H; Larson KJ; Cheng WH; Bukowski MR; Safratowich BD; Liu Z; Hakkak R
    J Nutr Biochem; 2020 Apr; 78():108336. PubMed ID: 32004929
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nuciferine Protects Against High-Fat Diet-Induced Hepatic Steatosis
    Sun J; Fan J; Li T; Yan X; Jiang Y
    J Agric Food Chem; 2022 Sep; 70(38):12014-12028. PubMed ID: 36106619
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intestinal farnesoid X receptor signaling promotes nonalcoholic fatty liver disease.
    Jiang C; Xie C; Li F; Zhang L; Nichols RG; Krausz KW; Cai J; Qi Y; Fang ZZ; Takahashi S; Tanaka N; Desai D; Amin SG; Albert I; Patterson AD; Gonzalez FJ
    J Clin Invest; 2015 Jan; 125(1):386-402. PubMed ID: 25500885
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protective effect of agaro-oligosaccharides on gut dysbiosis and colon tumorigenesis in high-fat diet-fed mice.
    Higashimura Y; Naito Y; Takagi T; Uchiyama K; Mizushima K; Ushiroda C; Ohnogi H; Kudo Y; Yasui M; Inui S; Hisada T; Honda A; Matsuzaki Y; Yoshikawa T
    Am J Physiol Gastrointest Liver Physiol; 2016 Mar; 310(6):G367-75. PubMed ID: 26767984
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ginsenoside Rg
    Shi Y; Chen J; Qu D; Sun Q; Yu Y; Zhang H; Liu Z; Sha J; Sun Y
    Nutrients; 2024 Mar; 16(6):. PubMed ID: 38542753
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A botanical dietary supplement from white peony and licorice attenuates nonalcoholic fatty liver disease by modulating gut microbiota and reducing inflammation.
    Chen L; Kan J; Zheng N; Li B; Hong Y; Yan J; Tao X; Wu G; Ma J; Zhu W; Sheng L; Chen L; Li B; Zhong J; Du J; Li H
    Phytomedicine; 2021 Oct; 91():153693. PubMed ID: 34403877
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Understanding the Role of the Gut Microbiome and Microbial Metabolites in Non-Alcoholic Fatty Liver Disease: Current Evidence and Perspectives.
    Vallianou N; Christodoulatos GS; Karampela I; Tsilingiris D; Magkos F; Stratigou T; Kounatidis D; Dalamaga M
    Biomolecules; 2021 Dec; 12(1):. PubMed ID: 35053205
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 1-Deoxynojirimycin improves high fat diet-induced nonalcoholic steatohepatitis by restoring gut dysbiosis.
    Zheng J; Zhu L; Hu B; Zou X; Hu H; Zhang Z; Jiang N; Ma J; Yang H; Liu H
    J Nutr Biochem; 2019 Sep; 71():16-26. PubMed ID: 31272028
    [TBL] [Abstract][Full Text] [Related]  

  • 39. FXR Signaling-Mediated Bile Acid Metabolism Is Critical for Alleviation of Cholesterol Gallstones by
    Ye X; Huang D; Dong Z; Wang X; Ning M; Xia J; Shen S; Wu S; Shi Y; Wang J; Wan X
    Microbiol Spectr; 2022 Oct; 10(5):e0051822. PubMed ID: 36036629
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Suppressed hepatic bile acid signalling despite elevated production of primary and secondary bile acids in NAFLD.
    Jiao N; Baker SS; Chapa-Rodriguez A; Liu W; Nugent CA; Tsompana M; Mastrandrea L; Buck MJ; Baker RD; Genco RJ; Zhu R; Zhu L
    Gut; 2018 Oct; 67(10):1881-1891. PubMed ID: 28774887
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 110.